Friday, March 20, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Contrarian

Why We Love Committees

Daily Remedy by Daily Remedy
July 31, 2022
in Contrarian
0
Why We Love Committees

Confident diverse group of hospital administrators sit down to discuss important issues withe healthcare professionals.

Healthcare loves committees. We have them everywhere. Seemingly, every bureaucratic organization in healthcare is administered through a loose conglomerate of individuals held together under the aegis of a committee.

Most never question why it is this way. We just accept it as tradition, like the sanctity of the clinical exam. We know of better ways to do things, but we still do it. But the concept of the committee is more telling than just healthcare’s deference to tradition. It reveals much about how we think in healthcare.

We think in groups, and the most dominant voice in the room influences the group the most. The idea being clinical medicine is egalitarian, so the strongest clinical minds should have the most sway. This makes sense if a committee is reviewing patient diagnosis, but it makes less sense for less clinical matters.

When discussing whether to add a new facility or to break ground on a new hospital, the talking points are not only clinical, but economic. The manner in which we make these decisions should differ from in how most we make clinical decisions. Yet, they are not.

They are grander extensions of the same committee design. Inevitably, the most dominant voices soon become the only voice and all others fall in line. This is how bureaucracies form in healthcare. Committees grow in size and scope, but the fundamental means of decision-making remain the same. So the same voice grows louder.

Whereas before the loudest voice had the strongest clinical acumen, now the loudest voice has the greatest sway. But the mechanisms of checks and balances get lost along the way. Bureaucracies exist for those in positions of power to exert it without being held liable.

In small clinical committees, if you are right or wrong, then you know it immediately. The effects of the decision are apparent. But for larger committees, the effects of the decision are less pronounced. It is difficult to say whether building the new hospital was the right decision.

This is because most decisions are not simply right or wrong. They depend on the context in which we decide. There is a science to this, the theory of committee decision-making. Mostly relegated to theoretical business and economic classes, the study of group decisions is not commonly applied in healthcare.

We like our tried-and-true model of loose committees with loose agendas. But as healthcare becomes more economic, the ability to make decisions becomes paramount. We cannot make clinical decisions the way we make economic ones. We have to learn when and how to optimize the decision-making process.

This is where the science of group decisions comes into play. We must frame how we derive consensus on decisions relative to the decisions being made. This starts with committee design. Different decisions are processed and discussed in group settings in different ways. It depends on the subject expertise of the committee members and the subject being discussed.

Financial committees should handle matters differently than clinical ones. And those who comprise one committee should not be on the other. This would require a certain level of delegation, divvying the decision-making among different groups.

But healthcare, for all its growth, remains beholden to its roots. And at its root lies the sole physician lording over all clinical decisions. We can discuss paternalism as subject expertise. We can even cover it up through the veneer of bureaucracy. But even underground, the roots make their presence known.

So committees retain their original structure, a loose mix of individuals in which the most dominant voice becomes the principal decision-making. And the more healthcare scales, the most pervasive those select voices become.

This is why healthcare loves committees so much.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

This episode explores deceptive pricing strategies in the GLP-1 medication market, highlighting how healthcare consumerism influences patient decisions and how to recognize and protect against misleading practices.

 key  topics

Deceptive pricing strategies in healthcare
The role of brand perception and pricing manipulation
The concept of drip pricing and hidden costs
The rise of healthcare consumerism and patient agency
Strategies for patients to identify and avoid deceptive practices

Chapters

00:00 The Evolution of the GLP-1 Telemedicine Market
01:12 How Pricing Is Obscured and Perceived Discounts Are Created
02:11 TrumpRx: Coupon Aggregator or Discount Store?
03:12 Why Price Deception Thrives in Healthcare
04:12 The Membership Fee Illusion and Hidden Costs
05:10 Brand Recognition and Drip Pricing Strategies
06:17 The Impact of Brand and Anchor Pricing on Perceived Value
07:16 The Role of Price Drip Strategies in Healthcare Pricing
08:15 The Rise of Healthcare Consumerism and Patient Agency
09:14 How to Protect Yourself from Deceptive Pricing Practices
10:09 Conclusion: Empowering Patients in a Complex Pricing Landscape
Unmasking Deceptive Pricing in Healthcare: What Patients Need to Know
YouTube Video zZgo1nLZVrY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

by Daily Remedy
March 1, 2026
0

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • A Call to Action for Pain Patients and Advocates

    A Call to Action for Pain Patients and Advocates

    1 shares
    Share 0 Tweet 0
  • America’s Medical Civil War

    0 shares
    Share 0 Tweet 0
  • The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    0 shares
    Share 0 Tweet 0
  • Healthcare’s Logistics Push

    0 shares
    Share 0 Tweet 0
  • Retatrutide and the Acceleration of Metabolic Medicine

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy